|
|
 |
|
|
|
|
| Your Result on : Balance Sheet |
|
|
|
|
| Ipca Laboratories Ltd |
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
|
|
|
|
| Book Value (Rs) |
|
| 271.6399623 |
|
|
|
|
|
|
Market Cap
(Rs In Cr.) |
|
| 33,050 |
|
|
|
|
|
|
|
|
|
|
|
|
| Year |
High (Rs) |
Low (Rs) |
Close (Rs) |
P/E High |
P/E Low |
P/E Close |
Mkt Cap.
(Rs In Cr.) |
| Oct 2025 |
1,404.10 |
1,252.95 |
1,272.20 |
44.84 |
38.29 |
39.35 |
32,276.25 |
| Sep 2025 |
1,507.95 |
1,302.00 |
1,341.35 |
49.19 |
40.04 |
41.49 |
34,030.62 |
| Aug 2025 |
1,520.45 |
1,325.00 |
1,380.90 |
50.21 |
40.60 |
42.71 |
35,034.02 |
| Jul 2025 |
1,594.55 |
1,356.00 |
1,473.30 |
52.02 |
41.45 |
45.57 |
37,378.24 |
| Jun 2025 |
1,430.35 |
1,322.35 |
1,388.30 |
44.46 |
39.74 |
42.94 |
35,221.76 |
| May 2025 |
1,520.00 |
1,326.70 |
1,423.95 |
48.65 |
40.15 |
44.04 |
36,126.21 |
| Apr 2025 |
1,516.50 |
1,200.00 |
1,396.55 |
47.52 |
34.23 |
43.19 |
35,431.06 |
| Mar 2025 |
1,525.00 |
1,281.05 |
1,501.30 |
49.84 |
38.54 |
46.43 |
38,088.61 |
| Feb 2025 |
1,530.95 |
1,338.40 |
1,353.45 |
65.81 |
55.97 |
57.24 |
34,337.60 |
| Jan 2025 |
1,757.65 |
1,375.05 |
1,443.00 |
75.37 |
57.80 |
61.02 |
36,609.52 |
| Share Prices Of
2024
|
| Dec 2024 |
1,698.65 |
1,470.70 |
1,693.75 |
72.04 |
61.18 |
71.63 |
42,971.15 |
| Nov 2024 |
1,625.00 |
1,475.35 |
1,543.40 |
69.42 |
59.89 |
65.27 |
39,156.71 |
| Oct 2024 |
1,708.70 |
1,453.25 |
1,587.80 |
73.45 |
59.85 |
67.15 |
40,283.16 |
| Sep 2024 |
1,527.95 |
1,375.70 |
1,496.70 |
66.76 |
58.01 |
63.29 |
37,971.91 |
| Aug 2024 |
1,429.50 |
1,215.00 |
1,383.85 |
61.57 |
48.57 |
58.52 |
35,108.86 |
| Jul 2024 |
1,323.10 |
1,114.00 |
1,307.35 |
56.63 |
46.38 |
55.29 |
33,168.02 |
| Jun 2024 |
1,219.05 |
1,060.95 |
1,134.20 |
53.14 |
41.97 |
47.96 |
28,775.13 |
| May 2024 |
1,370.00 |
1,146.70 |
1,152.10 |
61.85 |
48.27 |
48.72 |
29,229.26 |
| Apr 2024 |
1,373.95 |
1,216.75 |
1,338.75 |
59.02 |
51.12 |
56.61 |
33,964.65 |
| Mar 2024 |
1,245.00 |
1,121.25 |
1,238.25 |
52.94 |
46.95 |
52.36 |
31,414.92 |
|
| PREV |
NEXT
|
|
|
|
|
|
|
|
|
|